Displaying drugs 351 - 375 of 12795 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Lexaptepid pegol | Not Annotated | Lexaptepid pegol has been used in trials studying the treatment of Anemia, Inflammation, Chronic Diseases, End Stage Renal Disease, and Anemia of Chronic Disease. | Anti-Inflammatory Agents | |
Citrus bioflavonoids | Not Annotated | Not Annotated | Chromones / Flavonoids | |
2-(p-Tolyl)ethyl nicotinate | Not Annotated | A bile acid stimulant indicated to treat functional disorders of the gallbladder and bile ducts. | Not Annotated | |
NX-1207 | Not Available | Investigated for use/treatment in benign prostatic hyperplasia. | Amino Acids, Peptides, and Proteins | |
MPI-674 | Not Available | Investigated for use/treatment in menstrual disorders. | Not Available | |
Adomiparin | Not Annotated | Investigated for use/treatment in cardiovascular disorders and coronary artery disease. | Not Annotated | |
LY-3499446 | Not Annotated | Not Annotated | Not Annotated | |
Colestipol | Not Available | A bile acid sequestrant used as an adjunct to diet and exercise to reduce LDL-C cholesterol levels in patients with primary hypercholesterolemia. | Anion Exchange Resins / Bile Acid Sequestrants / Hypolipidemic Agents / Hypolipidemic Agents Indicated for Hyperlipidemia / Polyamines / Polymers / Sequestering Agents | |
Drinabant | Not Available | Investigated for use/treatment in alzheimer's disease, obesity, and schizophrenia and schizoaffective disorders. | Amides / Sulfones / Sulfur Compounds | |
RP01 | Not Available | Investigated for use/treatment in allergic reaction and asthma. | Not Available | |
PLN-74809 | Not Annotated | Through dual inhibition of integrins αvβ6 and αvβ1, PLN-74809 reduces subsequent activation of TGF-β1, which is actively involved in the growth of fibrotic tissue in lung and bile ducts .... | Experimental Unapproved Treatments for COVID-19 | |
NP-10679 | Not Annotated | Not Annotated | Not Annotated | |
XL765 | Not Available | For the treatment of various forms of cancer. | Phosphatidylinositol 3-Kinases, antagonists & inhibitors | |
ALKS 27 | Not Available | Investigated for use/treatment in chronic obstructive pulmonary disease (COPD). | Not Available | |
Polycarbophil | Not Available | Polycarbophil is used to treat constipation and to help maintain regular bowel movements. | Antidiarrheals / Bulk-Forming Laxatives / Laxatives | |
Maltodextrin | Not Annotated | Not Annotated | Carbohydrates | |
Amylopectin | Not Annotated | Amylopectin is under investigation in clinical trial NCT01708694 (Role of Slowly Digesible Starch on Diabetes Risk Factors). | Starch | |
VSF-173 | Not Available | Investigated for use/treatment in sleep disorders. | Not Available | |
KIN-3248 | Not Annotated | KIN-3248 is a small molecule that targets and inhibits oncogenic fibroblast growth factor receptors (FGFRs). It was designed to mainly target FGFR2 and FGFR3 alterations, which act as oncogenic drivers... | Not Annotated | |
XL019 | Not Available | For the treatment of various forms of cancer. | Not Available | |
IPH 1101 | Not Available | Investigated for use/treatment in hepatitis (viral, C), leukemia (myeloid), and lymphoma (non-hodgkin's). | Not Available | |
Omega-3-carboxylic acids | Not Available | A medication used with other medications to lower triglyceride levels in adult patients with severe hypertriglyceridemia. | Fatty Acids, Omega-3 | |
Mineral oil | Not Available | Mineral oil is not considered an active pharmacological ingredient in pharmaceutical preparations and so has no official indication. It is typically present in topical formulations as an emollient and occlusive... | Softeners, Emollients | |
Phenyl trimethicone | Not Annotated | Not Annotated | Compounds used in a research, industrial, or household setting / Macromolecular Substances / Organosilicon Compounds / Polymers / Silicon Compounds | |
GDC-1971 | Not Annotated | Not Annotated | Not Annotated |
Displaying drugs 351 - 375 of 12795 in total